FDA grants orphan drug status for Merck’s pembrolizumab in NEPC
Investing.com Gold reports: FDA grants orphan drug status for Merck’s pembrolizumab in NEPC. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: FDA grants orphan drug status for Merck’s pembrolizumab in NEPC. Full body text was unavailable at ingest time, so this brief is based on headline context.